Xero Shares Upgraded Into Melio Demo – Is A Rebound on The Cards?

Xero shares (ASX: XRO) have been upgraded by RBC Capital to Outperform from Sector Perform, citing attractive risk/reward following a punishing selloff that has seen the cloud accounting platform’s shares tumble 43.16% over the past year.

The upgrade comes at a critical juncture for Xero, with shares trading near 12-month lows following months of sustained selling pressure tied to concerns over its US$2.5 billion Melio acquisition.

RBC Capital has set a price target of A$155, representing a potential upside of 55% from current levels, though notably down from the firm’s previous A$170 target.

The revised target reflects both the stock’s dramatic repricing and lingering uncertainty around the integration of Melio, the US-based payments platform Xero acquired to accelerate its American expansion. Trading volumes have remained elevated as markets digest the implications of the substantial capital outlay against the backdrop of potential regulatory headwinds in the fintech payments space.

Core Details

Xero’s challenging year has been defined by the Melio transaction, which closed in October 2025 after the company raised A$1.85 billion through an institutional placement at A$176 per share—a 9.4% discount to the prevailing market price. The acquisition, aimed at enhancing Xero’s position in the lucrative US small business market, was met with immediate scepticism, sending shares down 9% on announcement day as markets weighed the strategic merits against execution risks.

Despite the share price weakness, Xero’s underlying business has continued to deliver solid operational performance. In November 2025, the company reported first-half results showing operating revenue up 20% year-on-year to NZD1.19 billion, with subscriber numbers climbing 10% to 4.59 million. However, even these positive metrics failed to arrest the share price decline, with the stock falling 4.8% following the results announcement as markets remained fixated on Melio integration concerns and profitability questions.

The investment case took another hit in March 2025 when RBC Capital initially downgraded Xero from Outperform to Sector Perform, slashing the price target from A$230 to A$187. That downgrade was triggered by reports that JPMorgan was considering implementing data and access fees for fintech payment providers operating in the US market. RBC estimated such fees could impact Xero’s gross profit by up to 1% and EBITDA by up to 5%, with more severe consequences if other major banks followed suit.

Outlook and Analysis

RBC Capital’s latest upgrade reversal suggests the firm believes much of the negative news is now priced into Xero’s battered share price. The catalyst for renewed optimism centres on an upcoming Melio product demonstration scheduled for next week, which could provide markets with tangible evidence of the acquisition’s strategic value and integration progress. The demonstration represents a critical opportunity for management to articulate how Melio’s bill payment capabilities will enhance Xero’s core accounting platform and drive customer value in the crucial US market.

The technical picture shows Xero trading at levels not seen since early 2023, with the 43% decline creating what some analysts view as a compelling entry point for long-term investors willing to look through near-term integration noise. The company’s core subscription business remains robust, with consistent double-digit revenue growth and an expanding customer base providing a solid foundation even as markets debate the Melio thesis.

However, significant uncertainty persists around the regulatory environment for fintech payments in the United States. The potential for major banks to impose access fees on platforms like Melio represents a structural risk that could materially impact the unit economics of the acquisition. Additionally, the A$3.9 billion price tag for Melio, representing a substantial premium to Xero’s market capitalisation at current levels, means the company must execute flawlessly on integration and cross-selling to justify the investment.

The upcoming product demonstration will be closely scrutinised by markets seeking reassurance that Xero can successfully integrate Melio’s technology, navigate the evolving US regulatory landscape, and deliver the revenue synergies that underpin the acquisition rationale. With the stock trading at a 55% discount to RBC’s revised price target, the risk/reward equation has shifted meaningfully in favour of buyers, provided management can demonstrate credible progress on the Melio integration roadmap.